NxStage Medical Revenue and Competitors
Estimated Revenue & Valuation
- NxStage Medical's estimated annual revenue is currently $300M per year.
- NxStage Medical's estimated revenue per employee is $436,681
- NxStage Medical's total funding is $5.6M.
Employee Data
- NxStage Medical has 687 Employees.
- NxStage Medical grew their employee count by 0% last year.
NxStage Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.5M | 38 | 3% | N/A | N/A |
#2 | $8.3M | 33 | 14% | N/A | N/A |
#3 | $4M | 16 | 33% | N/A | N/A |
#4 | $4.3M | 17 | -6% | N/A | N/A |
#5 | $5630M | 6953 | 4% | $450M | N/A |
#6 | $4M | 16 | 33% | N/A | N/A |
#7 | $7.2M | 57 | 27% | $29.6M | N/A |
#8 | $14.1M | 56 | 0% | N/A | N/A |
#9 | $2.1M | 17 | 31% | $44M | N/A |
#10 | $40.9M | 163 | -23% | N/A | N/A |
What Is NxStage Medical?
NxStage Medical, Inc. was founded in 1998 to develop and market novel technologies for the treatment of kidney failure. The NxStage System One is a breakthrough design that delivers hemodialysis, hemofiltration, and/or ultrafiltration to patients with renal failure or fluid overload. The system is compact and portable; it requires only a standard electrical outlet and no water processing. Its user-friendly interface and drop-in, disposable cartridge are designed for ease-of-use and streamlined training.
keywords:saas$5.6M
Total Funding
687
Number of Employees
$300M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NxStage Medical News
& Nxstage Medical, Inc.. Staying ahead in business is often about being the first; check the pulse of Kidney Dialysis Centers Market know what...
Ltd., NxStage Medical Medicators, Fresenius Medical Care AG & Co. KGaA, B. Braun Avitum AG, Diaverum Deutschland GmbH, NiproCorporation,...
... NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical ... Dialysis Devices are medical equipment and consumables that help in...
NxStage Medical (NSDQ:NXTM) shares are up today after the home hemodialysis company reported better-than-forecast results for the 4th quarter and 2014 and said it opened 2 new dialysis centers in the Boston area. Lawrence, Mass.-based NxStage pared its losses by 3.9% to -$5.0 million, or -8¢ pe ...
LAWRENCE, Mass. — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance. The OneSite employs a unique dual lumen needle design offered in both a sharp version with MasterGu ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $195M | 774 | N/A | N/A |
#2 | $284.8M | 1130 | 7% | N/A |
#3 | $371.2M | 1473 | N/A | N/A |
#4 | $564.7M | 1494 | 2% | N/A |
#5 | $586.3M | 1551 | -1% | N/A |